Clinical Trial Update: Remodulin® to Oral Treprostinil Transition [Phase 2]

View source ↗

Summary

Phase 2 trial results update evaluating transitioning patients with pulmonary arterial hypertension from Remodulin (treprostinil) to oral treprostinil. The resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Orenitram (treprostinil)
• Remodulin (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2016-05-16